The global infectious disease diagnostics market is expected to rise at a CAGR of 7.2 percent from USD 28.1 billion in 2021 to USD 39.8 billion in 2026. The global incidence of infectious diseases and the emergence of COVID-19, as well as rising awareness for early disease identification, a shift in focus from centralised laboratories to distributed POC testing, and technical improvements, are driving market expansion. Infectious disease prevalence in both established and developing nations will boost the infectious disease diagnostics market's growth. The rising number of prescriptions for infectious disease diagnostic tests is due to the diagnosis and management of such disorders. During the projection period, these factors, combined with the growing tendency toward preventative care, are projected to increase demand for infectious disease diagnostics.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Detection and variant characterization of lumpy skin disease virus (LSDV) from dairy cattle in India
Manali Bajpai, CSIR-National Chemical Laboratory, India
Title : Acceptability of mass drug administration for lymphatic filariasis in Baglung municipality of Nepal: A mixed-method study
Muskan Pudasainee, Pokhara University, Nepal